Status:
UNKNOWN
Microchimeric Cell Tranfer From Mother to Child - Pilo Study
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Breastfeeding
Eligibility:
MALE
1-16 years
Brief Summary
Microchimeric cells are known to be transferred from mother to child through the placenta. However it has been postulated that they could also be transferred through breastfeeding. This study is desi...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- age 1-16 years (at the time of surgery)
- male
- known breastfeeding status in infancy
- Exclusion criteria:
- premature birth (before 37 weeks)
- history of blood transfusion
- history of bone marrow transplant
- history of organ transplant
- patient known to have a twin
- known gonosomal
Exclusion
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05250219
Start Date
September 1 2021
End Date
December 31 2022
Last Update
February 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34280